Page 10 of 15 · 360 questions tagged semaglutide.
SOUL tested oral semaglutide 14 mg daily in people with type 2 diabetes and either atherosclerotic cardiovascular disease or chronic kidney disease, and reported a…
The specifics, since they change the answer: SURMOUNT-OSA · semaglutide. I would like to know whether this claim survives contact with evidence. If the answer is…
What I have: PIONEER-1 · dulaglutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Details up front: FLOW · retatrutide. I can parse the result. I am less sure what it licenses me to conclude. I have deliberately not looked at anyone else’s…
Conditions: STEP 2 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result,…
The specifics, since they change the answer: ESSENCE · semaglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…
Setup, so nobody has to ask: STEP 5 · a GLP-1 receptor agonist. This is asserted often enough that I assumed it was established, and then I went looking for the…
The case in front of me: SURMOUNT-4 · tirzepatide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Stated plainly: SURPASS-3 · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have searched the…
The case in front of me: ESSENCE · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if…
The clinician who ordered the panel was not concerned; I would still like to understand it. I keep seeing this stated as a fact with no explanation attached, and…
Stated plainly: TRIUMPH-1 · a GLP-1 receptor agonist. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
My laboratory results are from the same laboratory each time, drawn fasting, which I gather matters. I keep seeing this stated as a fact with no explanation attached,…
Setup, so nobody has to ask: SURPASS-2 · mazdutide. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The case in front of me: STEP 3 · oral semaglutide. The figures are clear enough; the question is what they mean and what they do not. I can supply the numbers if the…
The case in front of me: REDEFINE-1 · oral semaglutide. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a…
Details up front: SUSTAIN-6 · dulaglutide. This is presented as though it settles something, and I am not convinced it does. I have two documents that appear to…
Setup, so nobody has to ask: SUSTAIN-6 · cagrilintide. This is asserted often enough that I assumed it was established, and then I went looking for the source. I have…
What I have: TRIUMPH-3 · orforglipron. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The case in front of me: STEP 1 · tirzepatide. I want to know whether there is evidence behind this or only repetition. I have checked the obvious registries and…
Details up front: cagrilintide · semaglutide. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
What I am working with: ATTAIN-1 · cagrilintide. I have read the primary source rather than the summary, which has left me with more questions. I understand the…
Details up front: PIONEER-4 · dulaglutide. I would rather be corrected now than propagate something wrong. I am specifically not interested in a testimonial; I am…
The specifics, since they change the answer: STEP 2 · semaglutide. I have the document in front of me and I can read the numbers. What I cannot do is interpret them.…